http://wso.sagepub.com/content/11/1/117.abstract?
- Philippe Garrigue1,2,3
- Laura Giacomino4
- Chiara Bucci5
- Valeria Muzio5
- Maria A Filannino5
- Florence Sabatier1,6
- Françoise Dignat-George1,7
- Pascale Pisano1,8
- Benjamin Guillet1,2,3⇑
- 1INSERM, INSERM UMR_S1076 VRCM Aix-Marseille Université, France
- 2APHM, Hôpital La Timone, Service de Radiopharmacie, Marseille, France
- 3CERIMED, Aix-Marseille Université, Marseille, France
- 4Département Anesthésie-Réanimation adulte, APHM, Aix-Marseille Université, Marseille, France
- 5Advanced Accelerator Applications, Colleretto Giacosa (TO), Italy
- 6APHM, Laboratoire de Culture et Thérapie Cellulaire, INSERM, Hôpital La Conception, Marseille, France
- 7APHM, Hôpital La Conception, Service d’Hématologie, Marseille, France
- 8APHM, Pôle Pharmacie, Marseille, France
- Benjamin Guillet, Faculté de Pharmacie, 27 Bd Jean Moulin, 13005 Marseille, France. Email: benjamin.guillet@univ-amu.fr
Abstract
Background Cerebral
ischemia is a leading cause of disability worldwide and no other
effective therapy has been validated to date than
intravenous thrombolysis. In this context, many
preclinical models have been developed and recent advances in
preclinical
imaging represent promising tools. Thus, we
proposed here to characterize in vivo time profiles of cerebral blood flow, blood–brain barrier disruption and apoptosis following a transient middle cerebral
artery occlusion in rats using SPECT/CT imaging.
Methods Rats underwent
a 1-h middle cerebral artery occlusion followed by reperfusion.
Cerebral blood flow, blood–brain barrier disruption
and apoptosis were evaluated by SPECT/CT imaging
using respectively 99mTc-HMPAO, 99mTc-DTPA and the experimental 99mTc-Annexin V-128, up to 14 days after middle cerebral artery occlusion. Histological evaluation of apoptosis has been performed
using TUNEL method to validate the 99mTc-Annexin V-128 uptake.
Results 99mTc-HMPAO cerebral blood flow evaluation showed hypoperfusion during occlusion, partially restored on days 4 and 7 and sustained
up to 14 days after middle cerebral artery occlusion. 99mTc-DTPA SPECT/CT showed a blood–brain barrier disruption starting on day 1 post-middle cerebral artery occlusion, peaking
on day 2, with barrier integrity totally restored on day 7. 99mTc-Annexin
V-128 SPECT/CT imaging showed significant positive correlation with
TUNEL immunohistochemistry and allowed ischemic-induced
apoptosis to be detected from day 2 to day 7,
peaking on day 3 after middle cerebral artery occlusion.
Conclusions Using
SPECT/CT imaging, we showed that after transient middle cerebral artery
occlusion in rat there was a sustained decrease
in cerebral blood flow followed by blood–brain
barrier disruption preceding meanwhile apoptosis. Rodent SPECT/CT
imaging of
cerebral blood flow, blood–brain barrier
disruption and apoptosis appears to be an efficient tool for evaluating
neuroprotective
drugs and regenerative therapies against
cerebral ischemia and time-windows for therapeutic intervention.
No comments:
Post a Comment